The Dallas-based company, founded in 2012, has created a wearable technology called KneeStim that uses muscle stimulation and machine learning to turn everyday activity into on-the-go physical therapy. Their target market is the $5 billion knee treatment market, specifically focusing on providing mobile quadriceps strengthening and re-education for the 14 million plus individuals seeking conservative, cost- and time-efficient knee treatment. Articulate Labs has a working prototype, conducted a feasibility study, and has several patents issued and pending. They have also received independent market validation and have established a regulatory pathway and identified reimbursement codes. While the device has not yet been cleared by the FDA for marketing, the company aims to make physical rehabilitation more accessible, convenient, and effective by leveraging everyday activity to combat muscle atrophy and inhibition related to chronic conditions or surgery.